Patient Outcomes, Lived Experiences and Clinical Presentation Following Severe Shoulder Injury

Summary

The purpose of this study is to determine if youth and young adults with a history of severe shoulder injuries in the past 5-15 years differ in musculoskeletal characteristics such as shoulder strength, flexibility, and performance; quality of life; mental health; and activity levels compared to individuals with no history of shoulder injury. We would also like to understand individual lived experiences and perceptions of shoulder joint health following a severe shoulder injury experienced during youth sport participation.

All participants will be asked to complete online questionnaires (~45 minutes) and an in-person shoulder assessment (~45 minutes) at the University of Calgary. Participants who have had a severe, youth sport-related shoulder injury will also be asked to complete a 45-minute interview regarding their experiences with their shoulder injury.

Eligibility

Currently recruiting participants: Yes

Eligible gender: Male, Female, Transgender, Other

Eligible ages: 15 to 33

Accepts healthy participants: Yes

Inclusion criteria:

1) You are 15-33 years old
2) You sustained at least one youth sport-related severe shoulder injury 5-15 years ago that was assessed by an athletic therapist, physiotherapist or physician and resulted in time loss from sport of 4 weeks or more OR you have no history of shoulder, elbow, acromioclavicular (AC) joint and cervical injuries.

Exclusion criteria:

1) Musculoskeletal injury within 3 months, prior to testing, resulting in time loss from work, school, or sport
2) Orthopedic surgery in the last 6 months
3) Pregnancy at the time of assessment
4) Any other medical condition that prevents participation in the functional or clinical testing (i.e., neurological symptoms, disorder)

Participate

Fill out the following form if you want to participate in this research

Method of contact

Additional information

Contact information

If you are interested in participating, please contact the study research coordinator.

Principal investigator:

Carolyn Emery

Clinical trial:

No

REB-ID:

REB24-0397